Epstein–Barr virus: 40 years on

By L. Young, A. Rickinson. Nature Reviews. Cancer, 2004

2,275 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Post-transplant Lymphoproliferative Disorders: Implications for Targeted Therapy (2012, background): “nism for the observed expression of PD-L1 in other malignancies with constitutive AP-1 activity such as anaplastic large cell lymphoma (7, 46, 47) and melanoma (48) and bases for further analyses of the PD-1 pathway in additional EBV-associated tumors (2, 49).”
HUMAN VIRAL ONCOGENESIS: A CANCER HALLMARKS ANALYSIS (2014, background): “In immunocompetent individuals Lat III B-cells are eliminated by the immune system (Thorley-Lawson, 2001; Young and Rickinson, 2004) (Figure 2).”
EBV Positive Mucocutaneous Ulcer – A study of 26 cases associated with various sources of immunosuppression (2010, background): “Key molecular pathways controlling the cell cycle, such as NF-kB, are activated and virus-induced cytokines exert paracrine proliferative effects.(28,35,38,70) In physiologic circumstances the inherent propensity of EBV to induce B-cell proliferation is counterbalanced by complex immunologic interac”